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Abstract
Background: Cardiovascular magnetic resonance (CMR) phase contrast (PC) flow measurements suffer from phase
offset errors. Background subtraction based on stationary phantom measurements can most reliably be used to
overcome this inaccuracy. Stationary tissue correction is an alternative and does not require additional phantom
scanning. The aim of this study was 1) to compare measurements with and without stationary tissue correction to
phantom corrected measurements on different GE Healthcare CMR scanners using different software packages and
2) to evaluate the clinical implications of these methods.
Methods: CMR PC imaging of both the aortic and pulmonary artery flow was performed in patients on three
different 1.5 T CMR scanners (GE Healthcare) using identical scan parameters. Uncorrected, first, second and third
order stationary tissue corrected flow measurement were compared to phantom corrected flow measurements, our
reference method, using Medis QFlow, Circle cvi42 and MASS software. The optimal (optimized) stationary tissue
order was determined per scanner and software program. Velocity offsets, net flow, clinically significant difference
(deviation > 10% net flow), and regurgitation severity were assessed.
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Results: Data from 175 patients (28 (17–38) years) were included, of which 84% had congenital heart disease. First,
second and third order and optimized stationary tissue correction did not improve the velocity offsets and net flow
measurements. Uncorrected measurements resulted in the least clinically significant differences in net flow
compared to phantom corrected data. Optimized stationary tissue correction per scanner and software program
resulted in net flow differences (> 10%) in 19% (MASS) and 30% (Circle cvi42) of all measurements compared to
18% (MASS) and 23% (Circle cvi42) with no correction. Compared to phantom correction, regurgitation
reclassification was the least common using uncorrected data. One CMR scanner performed worse and significant
net flow differences of > 10% were present both with and without stationary tissue correction in more than 30% of
all measurements.
Conclusion: Phase offset errors had a significant impact on net flow quantification, regurgitation assessment and
varied greatly between CMR scanners. Background phase correction using stationary tissue correction worsened
accuracy compared to no correction on three GE Healthcare CMR scanners. Therefore, careful assessment of phase
offset errors at each individual scanner is essential to determine whether routine use of phantom correction is
necessary.
Trial registration: Observational Study
Keywords: Flow quantification, Cardiovascular magnetic resonance imaging, Phase contrast velocity imaging, Phase
offset error
Introduction
Cardiovascular magnetic resonance (CMR) 2D-phase con-
trast (PC) imaging is used to quantify blood flow in the
great arteries. Spins moving along a magnetic field gradi-
ent acquire a shift in their phase of rotation in comparison
to stationary spins. This phase shift is proportional to the
velocity of blood [1]. The net flow is calculated by integra-
tion of the velocity over time per heartbeat and taking a
second integral over the cross-sectional area of the vessel.
Flow quantification is helpful for assessment of valvular
regurgitant fraction and shunts, and often have important
therapeutic consequences in deciding whether valvular
surgery is necessary [2].
Common measurement errors of PC imaging include
mismatched encoding velocity, deviation of the imaging
plane, inadequate temporal resolution and spatial resolution
and phase offset errors [1]. These errors can be overcome
during scanning when the scanning operator is appropri-
ately trained, except for phase offset errors [3, 4]. Phase off-
set errors are errors caused by non-compensated eddy-
current-induced fields and concomitant gradient terms [1,
3]. Phase offset errors result in velocity offsets, meaning the
measured velocities deviate from the actual velocities. The
extent of this error depends on gradient imbalance due to
eddy currents, Maxwell terms and gradient field nonlinear-
ity [5–8]. A general correction for phase offset errors is not
possible as the severity of phase offset errors and influence
on uncorrected flow measurements vary greatly per specific
acquisition and across CMR systems [9].
Reliable background offset correction is necessary. Sta-
tionary tissue correction is a method available in many
(commercial) software applications. The velocity offset
in stationary tissue is used to estimate the velocity offset
at the vessel of interest. Most commonly, interpolation
methods which assume a linear variation over the field-
of-view are used. This method does not require acquisi-
tion of additional CMR sequences. However, stationary
tissue is most frequently not directly located next to the
vessel of interest and the magnitude of phase offset er-
rors varies spatially over the imaging plane. With the off-
set information in stationary tissue, the magnitude of
phase offset errors is estimated at the vessel of interest.
Phantom correction is another approach to correct flow
measurements for phase offset errors. With flow mea-
surements in a stationary phantom, the magnitude of
the phase offset errors at the location of the vessel of
interest is assessed. This method assumes temporal sta-
bility of the phase offset errors and requires extra acqui-
sitions and time, as every individual acquisition needs its
own stationary phantom acquisition.
Recently, stationary tissue correction has been shown
to reduce phase offset errors to minimal and clinically
acceptable differences in small groups of patients with
efficacy comparable to phantom measurements [10].
Therefore, the purpose of this study was 1) to compare
stationary tissue corrected and uncorrected flow mea-
surements with phantom corrected flow measurements
in a large group of patients in daily clinical practice, 2)
to assess the variation of phase offset errors across dif-
ferent CMR systems and 3) to investigate the impact of
phase offset errors on regurgitation severity indexing.
Methods
Study population
In this retrospective study, all consecutive patients and
healthy volunteers that underwent a CMR on one of our
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three clinical 1.5 T CMR systems used for cardiac scan-
ning were screened. The inclusion criteria were availabil-
ity of 2D-PC images with both through-plane flow of the
aorta and main pulmonary artery and concomitant sta-
tionary phantom acquisitions. Both pediatric and adult
patients were included as well as patients with and with-
out shunt. There was no selection in referral to a specific
scanner except that the majority of pediatric patients
were scanned on one of the three scanners because of its
location in our children’s hospital. Only patients with
mechanical aortic or pulmonary valves were excluded
due to potential imaging artifacts. Of each patient, age,
sex, biometric data, diagnosis, presence of shunt lesions,
valve type, and valvular disease were collected. Since this
is a purely observational and retrospective study, the
need for ethics committee approval was waived by the
institutional review board (MEC-2019-0155). All healthy
subjects were prospectively recruited and provided in-
formed consent (MEC-2014-096).
CMR protocol
CMR imaging was performed on the following three dif-
ferent clinical 1.5 T CMR scanners from General Electric
Healthcare (Milwaukee, Wisconsin, USA): Signa Artist
with software version DV26.0 (CMR-1), Discovery
MR450 with DV25.0 (CMR-2), and Signa Explorer with
DV25.0 (CMR-3). Characteristics of the different systems
are shown in Additional file 1. Included patients had
undergone a CMR examination with at least PC and cine
imaging. Through plane 2D PC flow measurements of
the aorta and pulmonary artery were performed during
end-expiratory breath-hold using retrospective electro-
cardiographic (ECG) gating. The imaging planes were
planned perpendicular to the great vessels. Aortic PC
imaging was scanned at the aortic valve and pulmonary
PC imaging was scanned approximately 1 cm above the
valve proximal to the pulmonary bifurcation. The same
sequence parameters were used on all three scanners:
field-of-view (FOV) 31–38 cm, phase FOV 75–100%,
slice thickness 7 mm, matrix size 192 × 160, flip angle
20°, echo time 3.4 ms (1.8–3.9), repetition time 5.8 ms
(4.7–6.5), ASSET 1.5, views per segment 4 to 6 based on
patients’ heart rate and 30 reconstructed cardiac phases.
Standard velocity encoding (VENC) value was set at 180
cm/s, however, increased in gradual steps up to 500 cm/
s if necessary, and flow compensation was used. Phase
errors due to Maxwell/concomitant gradient terms were
corrected within the image reconstruction and flow
optimization was turned on to limit gradient slew rates
in order to minimize eddy currents as advised by the
vendor [10]. During PC acquisition, the structure of
interest was aimed to be located in the magnetic isocen-
ter and local shimming was used.
Furthermore, cine imaging was performed using a
breath-hold segmented, balanced steady-state free pre-
cession sequence with a slice thickness of 6 mm and 4
mm interslice gap. Long and short axis images were
made so that the whole left ventricle (LV) and right ven-
tricle (RV) were covered from basis to apex.
Directly after the CMR examination, the exact same
PC sequence parameters were used to scan a static gel
phantom. The patient was positioned next to the scan-
ner, still connected to the ECG recording and phantom
acquisition was triggered based on the patients’ heart
rate. Phantoms consisted of a 10 L paraben (C10H12O3)
gelatin gel with 50mL Gadovist. This object was posi-
tioned at the identical location on the table where the
heart was located.
CMR analysis
Currently, multiple software programs are available to
analyze flow acquisitions. Medis software (QMass soft-
ware version 8.1 and QFlow software version 2.3, Medis,
Leiden, The Netherlands), Circle Cardiovascular Imaging
(cvi42 version 5.11.2, Circle Cardiovascular Imaging,
Calgary, Canada) and MASS research software (Version
2016EXP, Leiden University Medical Centre, Leiden,
The Netherlands) were used to analyze the CMR images
to assess also variability between software programs.
For PC velocity analysis, the aorta and pulmonary ar-
tery were manually delineated in at least one cardiac
phase (Fig. 1a and b). Automatic border detection was
used for the other cardiac phases. These contours were
reviewed and adapted accordingly for each cardiac
phase. The same contours were used for analysis in
MASS and Medis QFlow. For the analysis in Circle
cvi42, separate contours were drawn. The net flow per
cardiac phase was calculated by integration of the vel-
ocity per cardiac phase and taking a second integral over
the vessel area.
Net flow was defined as total forward flow minus total
regurgitation flow over 30 cardiac phases, which equals
one heartbeat. This net flow was measured in mL per
heartbeat and, subsequently, corrected for body surface
area. Regurgitation fraction was calculated by dividing
the regurgitation flow by the forward flow × 100%. Aor-
tic valve regurgitation was graded as none (< 5%), mild
(5–20%), moderate (20–33%) and severe (> 33%) [11].
Pulmonary regurgitation was defined as none (< 5%),
mild (5–20%), moderate (20–40%) and severe (> 40%)
[12]. Aortic and pulmonary valve stenosis were defined
as a peak systolic velocity of ≥3m/s. Qp/Qs ratio was de-
fined as pulmonary flow divided by systemic flow and a
shunt lesion was defined as Qp/Qs > 1.5 in phantom cor-
rected flow measurements [13].
Within each software, flow measurements were ana-
lyzed in three manners: 1) uncorrected flow
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measurements, 2) stationary tissue corrected flow mea-
surements (first order correction in all three software
programs and second and third order correction in
MASS and Circle cvi42), and 3) phantom corrected flow
measurements.
For stationary tissue correction, areas of phase wrap-
ping and cardiac structures were excluded. Within the
remaining region, in Medis QFlow and Circle cvi42 25%
and respectively 15% of all the pixels with the lowest
variation in velocity during the cardiac cycle were
regarded as stationary pixels (Fig. 1c and e). In MASS, of
each pixel the standard deviation of the velocity over the
cardiac cycle was calculated and pixels with a standard
deviation < 2.5 cm/s were considered as stationary tissue
(Fig. 1d). Based on these pixels, a linear (first order) and
tilted and curved (second and third order) interpolation
correction plane was made over the field-of-view. This
plane allowed to estimate phase offset error in nonsta-
tionary pixels, i.e. the area within the drawn contours
[3]. Subtracting the fitted surface from the phase image,
the stationary tissue corrected results were obtained.
The phantom corrected blood flow was determined by
subtraction of the phantom flow measurement from the
initial flow measurement on a pixel by pixel basis. Phan-
tom corrected flow measurements were used as refer-
ence standard. Net flow, regurgitation fraction, and Qp/
Qs ratio of uncorrected and stationary tissue corrected
measurements were compared to phantom corrected
flow measurements (Fig. 1f). The difference and absolute
difference (regardless of over- or underestimation) in net
flow were calculated in percentages. Differences of more
than 10% in net flow were considered as clinically sig-
nificant. Changes in regurgitation severity grading were
assessed comparing uncorrected and stationary tissue
corrected flow measurements with phantom corrected
flow measurements.
Finally, the contours of the vessel of interest were
imported onto the phantom images. Herewith, the initial
velocity offset was determined before any correction
method was applied. Also, the velocity offset after sta-
tionary correction was determined.
On the cine short-axis stack LV and RV endocardial
contours were manually traced in end-diastole and end-
systole according to Society for Cardiovascular Magnetic
Resonance guidelines on CMR image post-processing
[14]. Papillary muscles and trabeculations were excluded
from the endocardial contours and LV and RV end-
diastolic volume (EDV), end-systolic volume (ESV), and
ejection fraction (EF) were determined (analysis per-
formed with Medis QMass).
Phantom accuracy
Phantom corrected measurements were used as a refer-
ence. This method assumes temporal stability of the vel-
ocity offset over time [15]. Although we performed the
acquisition of the static phantom with identical slice
orientation and parameters directly after the examin-
ation using the heartbeat of the patients, the validity and
Fig. 1 Example of phase contrast cardiovascular magnetic resonance (CMR) with a) Velocity image b) Magnitude image c) Stationary tissue
detection in Medis QFlow d) Stationary tissue detection in MASS e) Stationary tissue detection in Circle cvi42 f) Examples of flow curves during 1
cardiac cycle measured with Circle cvi42 and shown for all different correction methods
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temporal stability of phantom correction method was
tested in all studies with a similar method as described
by Hofman et al. [10]. In short, a region of interest was
drawn in stationary tissue at the anterior thorax wall in
the PC image. This region-of-interest was copied onto
the corresponding phantom image and checked if the re-
gion was completely covered by phantom. Average vel-
ocity offset within this region over the cardiac cycle in
the in-vivo scan was compared to the velocity offset in
the phantom scan (measured with Medis QFlow). Only
if the agreement between these measurements was
within 0.6 cm/s, the study was included in our analysis [9].
Statistics
Continuous values were expressed as mean with stand-
ard deviation or as median with a range or interquartile
(IQR) range in cases of skewed distributions. Categorical
data were presented as frequencies and percentages. Dif-
ferences in velocity offset and net flow were tested for
significance using a paired T-test if normally distributed
and with a Wilcoxon signed rank test if not normally
distributed. Differences in net flow were also visualized
using root mean square (RMS) values. This gives a better
indication of the difference in the individual patient in-
dependently of over- or underestimation. Changes in
clinically significant differences were tested between cor-
rection methods with a McNemar’s test and between
scanners with a Chi-square test. Based on the number of
clinically significant differences, absolute velocity offset,
standard deviation of the velocity offset and RMS, the
optimal stationary tissue order per scanner and per soft-
ware program was determined. Linear regression was
used to investigate the association of uncorrected and
stationary tissue corrected measurements of net flow
and Qp/Qs ratios with phantom corrected net flow and
Qp/Qs ratios. Pearson correlations were calculated. A
weighted kappa was used to assess differences in regur-
gitation severity classification between correction
methods and phantom correction. Linear regression was
performed to identify the dependence of velocity offset
on velocity encoding (VENC), heart rate, vessel size,
maximum blood flow velocity, vessel location (aorta or
main pulmonary) and scanner. Forward method was
used for multivariate linear regression, in order to iden-
tify independent predictors for phase offset errors. Vari-
ables were entered in the model if the p-values was less
than 0.20.
Statistical analyses were conducted using SPSS (ver-
sion 25.0, Statistical Package for the Social Sciences,
International Business Machines, Inc., Armonk, New
York, USA) and R Statistical Software (version 3.6.1, R
Foundation for Statistical Computing, Vienna, Austria).
P-values of < 0.05 were considered statistically
significant.
Results
Phantom accuracy and study population
Initially 177 patients were included in this study includ-
ing 354 flow acquisitions. No studies were excluded due
to too much wraparound. In 19 of the 175 studies, small
areas of spatial wraparound were present and these areas
were manually excluded. First the accuracy of the phan-
tom correction method was tested. Median difference
between in-vivo stationary tissue measurements and
phantom measurements was − 0.1 (− 0.3 to 0.2) cm/s.
The assumption of stability of the velocity offset over
time (> 0.6 cm/s) was violated in two aortic flow exami-
nations and six pulmonary flow examinations within
three patients scanned on CMR-2 and three scanned on
CMR-3. Therefore, these eight studies were excluded
from further analysis. The final analysis consisted of 175
patients with 346 flow acquisitions.
Of the 175 included patients 76 were scanned on
CMR-1, 48 on CMR-2, and 51 on CMR-3. Patient
characteristics are summarized in Table 1. Patients
were 28 (17–38) years old, and 102 (58%) were male.
Of the included patients, 147 (84%) had a congenital
heart defect, of which tetralogy of Fallot was the most
prevalent diagnosis (60 patients (34%)). Patients
scanned on CMR-3 were younger and, therefore, the
dimensions of the aorta and main pulmonary artery
were smaller.
Velocity offset
Before correction, velocity offset was 0.0 ± 2.0 cm/s
(Medis QFlow), 0.1 ± 2.0 cm/s (MASS), and 0.0 ± 2.2 cm/
s (Circle cvi42) depending on the software program
used. The velocity offset using different software pro-
grams and for different order stationary tissue correction
methods is shown in Table 2 and Fig. 2. Overall,
interpolation-based correction did not improve the vel-
ocity offsets and the absolute velocity offset remained
large. With regard to the different CMR systems, CMR-
2 had a larger velocity offset than the other two systems
and there was a larger range in over- and underestima-
tion (Fig. 2, top row). The differences between the aortic
and pulmonary measurements are depicted in Fig. 2,
bottom row. Especially, first order correction did result
in larger velocity offset in the aortic images. The opti-
mized stationary tissue correction per scanner and soft-
ware was: (1) second order for CMR-1, third order for
CMR-2 and first order for CMR-3 for analyses in MASS
and (2) second order for CMR-1, first order for CMR-2
and third order for CMR-3 for analyses in Circle cvi42.
For further analyses, these optimized interpolation or-
ders were used as a separate stationary tissue correction
method and compared to uncorrected and phantom cor-
rected measurements.
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Net flow quantification
The mean phantom corrected net flow was 48 ± 11 mL/
m2 per heartbeat. There was a strong relationship be-
tween phantom corrected net flow and the net flow ob-
tained using the optimized stationary tissue correction
methods or the uncorrected net flow (Fig. 3 and Add-
itional file 2). The net flow obtained using MASS soft-
ware showed the strongest relationship with phantom
corrected net flow (Pearson’s r = 0.91, p < 0.001). Overall,
the mean difference and the absolute median difference
in net flow did not ameliorate significantly with station-
ary tissue correction compared to no correction (Table
2). On the contrary, it deteriorated with most
interpolation orders. Considering the percentage differ-
ences in net flow, uncorrected flow measurements re-
sulted systemically in the smallest difference on CMR-1
Table 1 Baseline table
CMR-1 (n = 76) CMR-2 (n = 48) CMR-3 (n = 51) Overall (n = 175)
Age 31 (25–42) 30 (20–40) 15 (11–21) 28 (17–38)
Age < 18 years 4 (5%) 5 (10%) 35 (69%) 44 (25%)
Range 12–68 16–66 5–64 5–68
Male 41 (54%) 32 (67%) 29 (57%) 102 (58%)
Weight (kg) 76 (65–86) 70 (56–80) 55 (40–70) 69 (55–81)
Height (cm) 174 (165–182) 174 (164–182) 162 (150–175) 172 (159–180)
Body surface area (BSA) (m2) 1.9 (1.7–2.1) 1.8 (1.6–2.0) 1.5 (1.3–1.9) 1.8 (1.6–2.0)
Heart rate (beats/min) 68 ± 12 71 ± 12 72 ± 13 70 ± 13
Diagnosis
Tetralogy of Fallot, PA + VSD 20 (26%) 15 (31%) 25 (49%) 60 (34%)
ASD 2 (3%) 1 (2%) 5 (10%) 8 (5%)
VSD 0 (0%) 4 (8%) 5 (10%) 9 (5%)
TGA 6 (8%) 5 (10%) 2 (4%) 13 (7%)
Valvular disease 28 (37%) 12 (25%) 12 (24%) 52 (30%)
Turner syndrome 7 (9%) 5 (10%) 0 (0%) 12 (7%)
Other 4 (5%) 5 (10%) 2 (4%) 11 (6%)
Healthy volunteer 9 (12%) 1 (2%) 0 (0%) 10 (6%)
Cardiac morphology & function
Shunt lesions 1 (1%) 3 (6%) 3 (6%) 7 (4%)
LV ejection fraction (%)a 55 (51–59) 55 (47–61) 57 (52–64) 55 (50–61)
LV end-diastolic volume (ml)a 155 (130–200) 164 (142–199) 144 (102–177) 155 (124–194)
LV end-systolic volume (ml)a 72 (57–89) 76 (58–100) 59 (40–86) 71 (53–89)
RV ejection fraction (%)a 52 (47–57) 52 (45–56) 53 (48–59) 52 (47–57)
RV end-diastolic volume (ml)a 190 (155–231) 216 (174–279) 170 (131–234) 192 (150–248)
RV end-systolic volume (ml)a 93 (67–120) 107 (79–137) 79 (54–117) 95 (63–123)
Aortic valve
Regurgitation 9 (12%) 8 (17%) 3 (6%) 20 (11%)
Stenosis 2 (3%) 2 (4%) 0 (0%) 4 (2%)
Bicuspid 14 (18%) 3 (6%) 2 (4%) 19 (11%)
Biological valve 4 (5%) 0 (0%) 0 (0%) 4 (2%)
Pulmonary valve
Regurgitation 25 (33%) 21 (45%) 23 (48%) 69 (40%)
Stenosis 6 (8%) 3 (6%) 2 (4%) 11 (6%)
Biological valve 10 (13%) 6 (13%) 7 (15%) 23 (13%)
Vessel size
Aorta (cm2) 5.5 (4.3–7.7) 5.9 (4.7–9.0) 4.7 (3.8–6.1) 5.3 (4.3–7.6)
Main pulmonary artery (cm2) 6.2 (4.9–7.3) 5.8 (4.7–7.5) 4.9 (4.0–5.8) 5.6 (4.5–7.2)
Values are presented as numbers (percentage), mean ± SD or median (interquartile range)
ASD Atrium septal defect, AVSD Atrioventricular septal defect, PA Pulmonary atresia, TGA Transposition of the great arteries, VSD Ventricular septal defect
a Data were missing in four patients
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and CMR-3 (Fig. 4). However, in spite of correction
methods and software packages, on CMR-2 substantial
over- and underestimation remained.
Consistent among the different software packages, sta-
tionary tissue correction resulted in significant more
measurements with clinically significant (> 10%) differ-
ences in net flow compared to no correction. The num-
ber of measurements with clinically significant
differences varied between 67 (19%) with optimized sta-
tionary tissue correction in MASS and 137 (40%) with
Table 2 Magnitude of flow change with and without offset correction
No
correction
Optimized
ST correction
1st order
correction
2nd order
correction
3rd order
correction
P-
value
no vs.
opt.
P-value
‡
no vs.
1st
P-value
‖
no vs.
2nd
P-value
$
no vs
3rd
Medis QFlow
Net flow (ml/m2)a 48 ± 13 – 47 ± 13 – – – – – –
Velocity offset (cm/s) 0.0 ± 2.0 – − 0.5 ± 1.8 – – – < 0.001 – –
Absolute velocity
offset (cm/s)
1.0 ± 1.7 – 1.3 ± 1.2 – – – < 0.001 – –
Difference in net flow with phantom correction (%)b
Difference 0.2 ± 15.4 – −3.2 ± 12.8 – – – < 0.001 – –
Absolute difference 3.3 (1.2 to
7.3)
– 6.1 (3.0 to 11.2) – – – < 0.001 – –
Range of difference − 78 to
155
– −66 to 74 – – – – – –
Clinically significant
differences (> 10%)
65 (19%) – 103 (30%) – – – < 0.001 – –
MASS
Net flow (ml/m2)a 48 ± 13 48 ± 12 47 ± 13 49 ± 13 48 ± 12 – – – –
Velocity offset (cm/s) 0.1 ± 2.0 0.0 ± 1.5 −0.3 ± 1.8 0.3 ± 1.6 0.3 ± 1.6 0.247 < 0.001 0.082 0.276
Absolute velocity
offset (cm/s)
1.0 ± 1.7 0.9 ± 1.2 1.3 ± 1.3 1.1 ± 1.2 1.1 ± 1.1 0.418 < 0.001 0.013 0.003
Difference in net flow with phantom correction (%)b
Difference 0.8 ± 15.6 −0.1 ± 11.1 −2.0 ± 13.0 2.7 ± 13.4 1.8 ± 12.2 0.379 < 0.001 0.060 0.281
Absolute difference 3.2 (1.3 to
7.2)
3.7 (1.5 to
8.5)
5.6 (2.4 to 10.4) 4.3 (1.6 to
9.3)
4.6 (2.2 to 9.2) 0.342 < 0.001 0.015 0.004
Range of difference −78 to 161 −35 to 101 −65 to 69 −58 to 101 − 37 to 120 – – – –
Clinically significant
differences (> 10%)
62 (18%) 67 (19%) 93 (27%) 74 (21%) 79 (23%) < 0.001 < 0.001 < 0.001 < 0.001
Circle cvi42
Net flow (ml/m2)a 47 ± 13 47 ± 13 45 ± 12 47 ± 13 47 ± 13 – – – –
Velocity offset (cm/s) 0.0 ± 2.2 −0.2 ± 2.0 − 0.7 ± 2.2 − 0.1 ± 2.1 − 0.1 ± 2.2 0.063 < 0.001 0.607 0.566
Absolute velocity
offset (cm/s)
1.2 ± 1.9 1.4 ± 1.5 1.7 ± 1.6 1.4 ± 1.6 1.5 ± 1.6 0.006 < 0.001 0.014 < 0.001
Difference in net flow with phantom correction (%)b
Difference 0.0 ± 16.0 −1.8 ± 14.3 −4.8 ± 15.0 − 0.5 ± 15.2 −0.7 ± 15.5 0.046 < 0.001 0.640 0.563
Absolute difference 4.1 (1.4 to
9.2)
6.0 (2.2 to
11.9)
8.0 (4.3 to 13.6) 5.3 (2.2 to
12.1)
6.1 (2.2 to 13.2) 0.005 < 0.001 0.011 < 0.001
Range of difference −93 to 131 −62 to 59 −66 to 59 − 85 to 71 −80 to 75 – – – –
Clinically significant
differences (> 10%)
80 (23%) 103 (30%) 137 (40%) 107 (31%) 115 (33%) < 0.001 < 0.001 < 0.001 < 0.001
Values are presented as mean ± standard deviation, median (interquartile range), range minimum to maximum or number (percentage)
Opt. Optimized stationary tissue (ST) correction
p-values no correction versus optimized ST correction, ‡ p-values no correction versus first order correction, ‖ p-values no correction versus second order
correction, $ p-values no correction versus third order correction
a Indicates net flow per heartbeat, with phantom correction the mean net flow was 48 ± 11ml/ m2 in all software packages, b Minus indicates flow was lower
compared to phantom flow measurements
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first order Circle cvi42 stationary tissue correction. For
uncorrected measurements, this varied between 62
(18%) with MASS and 80 (23%) with Circle cvi42 (Table
2). The frequency of clinically significant differences var-
ied substantially between scanners (Additional file 3).
For CMR-3, no correction was necessary, because in
only 1 (1%) of 99 measurements there was a clinically
significant difference in net flow of > 10% compared to
phantom correction.
Correlations of Qp/Qs ratios of uncorrected and station-
ary tissue corrected measurements compared to phantom
corrected measurements are shown in Additional file 4.
Both uncorrected and stationary tissue corrected flow
measurements were more likely to overestimate than to
underestimate Qp/Qs ratios. When looking at a cut off of
> 1.5 for having a hemodynamically significant shunt, no
correction and stationary tissue correction resulted in
more hemodynamically significant shunts compared to
phantom corrected data. With phantom corrected mea-
surements, 6 (Medis QFlow) to 7 (MASS and Circle cvi42)
patients had a hemodynamically significant shunt, whereas
with no correction or stationary tissue correction 10 (third
order stationary tissue correction MASS) to 21 (first order
stationary tissue correction Circle cvi42) patients had a
hemodynamically significant shunt. Incorrect shunt esti-
mation was most commonly caused by a relative overesti-
mation of pulmonary flow compared to aortic flow.
Regurgitation fraction
In general, regurgitation fraction was often overesti-
mated with uncorrected and stationary tissue corrected
measurements compared to phantom corrected mea-
surements. Depending on software package and correc-
tion method, regurgitation was incorrectly classified up
37% of the assessed vessel with first order Circle cvi42
software (Table 3). Taking aortic and main pulmonary
artery measurements together, second and third order
and optimized stationary tissue correction could not
categorize regurgitation better than no correction. Un-
corrected regurgitation severity had the strongest agree-
ment with phantom corrected regurgitation severity
(weighed kappa coefficient between 0.64–0.92 depending
on the software and vessel of interest), except for aortic
regurgitation severity using third order stationary tissue
correction from MASS and second order stationary tis-
sue correction from Circle cvi42. Additional file 5 shows
changes in aortic and pulmonary regurgitation severity
comparing no correction and stationary tissue correction
with phantom correction. Both stationary tissue and no
correction tended to overestimate aortic regurgitation,
whereas for pulmonary regurgitation there was no ten-
dency towards over- or underestimation. On CMR-3,
only in 2 (2%) of 99 measurements a change in regurgi-
tation severity occurred using the uncorrected
measurements.
Fig. 2 Velocity offset (cm/s) with no correction, first, second, third order and optimized stationary tissue correction measured in three different
software packages. Top row stratified by scanner and bottom row stratified by vessel of interest (aorta or main pulmonary artery (MPA))
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Uni- and multivariate prediction of phase offset errors
Higher velocity offsets were significantly associated with
higher maximum and average vessel size, VENC, max-
imum blood flow velocity, main pulmonary artery mea-
surements and scanning performed on CMR-2. CMR-2
had the strongest association (β = 1.73, p < 0.001, 95% CI
1.37–2.09). Maximum velocity (m/s) (β = 0.26, p = 0.03,
95% CI 0.02–0.49) and CMR-2 (β = 1.69, p < 0.001, 95%
CI 1.33–2.05) remained independently associated with
velocity offset in multivariate analysis. In multivariate
analysis, there was a trend for larger velocity offsets in
the main pulmonary artery measurements (β = 0.31, p =
0.06) than the aortic measurements, however, this was
not statistically different.
Discussion
The main finding of this study was that phase offset er-
rors have a large impact on PC based blood flow
Fig. 3 Scatterplots of net flow per body surface area (BSA) with phantom correction (x-axis) compared to uncorrected and optimized stationary
tissue correction (y-axis) measured with Medis QFlow, Circle cvi42 and MASS software programs. Black line is least-squares linear regression line,
dashed black line is x = y line. Pearson correlation coefficients are depicted with corresponding p-values
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Fig. 4 Root mean square (RMS) of the percentage difference in net flow between phantom correction and no correction, first, second, third
order and optimized stationary tissue correction measured in three different software packages
Table 3 Regurgitation reclassification comparing no and stationary tissue correction methods to phantom correction
Aortic valve (n = 175) Pulmonary valve (n = 171)
≥1
categorya
1
categoryb
≥2
categoriesc
Weighted
kappa
95% CI ≥1
categorya
1
categoryb
≥2
categoriesc
Weighted
kappa
95% CI
Medis QFlow
No correction 21 (12%) 19 (11%) 2 (1%) 0.69 0.55–0.83 16 (9%) 15 (9%) 1 (1%) 0.92 0.88–0.96
1st order
correction
36 (21%) 31 (18%) 5 (3%) 0.55 0.40–0.69 19 (11%) 18 (11%) 1 (1%) 0.90 0.86–0.94
MASS
No correction 21 (12%) 20 (11%) 1 (1%) 0.73 0.61–0.85 15 (9%) 14 (8%) 1 (1%) 0.92 0.88–0.96
Optimized ST
correction
22 (13%) 19 (11%) 3 (2%) 0.69 0.55–0.83 18 (11%) 18 (11%) 0 (0%) 0.91 0.88–0.95
1st order
correction
28 (16%) 22 (13%) 6 (3%) 0.62 0.49–0.76 22 (13%) 22 (13%) 0 (0%) 0.89 0.85–0.93
2nd order
correction
24 (14%) 19 (11%) 5 (3%) 0.60 0.43–0.76 23 (13%) 23 (13%) 0 (0%) 0.89 0.85–0.93
3rd order
correction
18 (10%) 15 (9%) 3 (2%) 0.73 0.59–0.87 23 (13%) 23 (13%) 0 (0%) 0.89 0.85–0.93
Circle cvi42
No correction 29 (17%) 27 (15%) 2 (1%) 0.64 0.51–0.78 15 (9%) 14 (8%) 1 (1%) 0.92 0.88–0.96
Optimized ST
correction
32 (18%) 27 (15%) 5 (3%) 0.61 0.48–0.74 35 (20%) 34 (20%) 1 (1%) 0.83 0.77–0.88
1st order
correction
64 (37%) 55 (31%) 9 (5%) 0.41 0.28–0.53 26 (15%) 25 (15%) 1 (1%) 0.87 0.82–0.92
2nd order
correction
24 (14%) 20 (11%) 4 (2%) 0.65 0.51–0.79 34 (20%) 32 (19%) 2 (1%) 0.83 0.77–0.88
3rd order
correction
27 (15%) 23 (13%) 4 (2%) 0.63 0.50–0.77 31 (18%) 28 (16%) 3 (2%) 0.84 0.78–0.89
Values are presented as number (percentage)
CI Confidence interval, ST Stationary tissue
a indicates number of studies in which regurgitation severity is reclassified with the different correction methods (no, 1st, 2nd or 3rd order) compared to phantom
corrected measurements; b number of studies in which regurgitation severity shifted only one category (e.g. from mild to moderate). c number of studies in which
regurgitation severity shifted with two categories or more (e.g. from none to moderate or mild to severe)
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quantification in daily clinical practice. This resulted in
clinically significant flow differences in 18–23% of the
measurements depending on the analysis software pro-
gram used and had a substantial impact on regurgitation
classification. Surprisingly, stationary tissue correction
independent of the order of interpolation (first, second
and third) or even optimized per scanner and software
program did not improve the accuracy of the flow mea-
surements, but generally worsened the results. Results of
our analyses acquired with three different software pack-
ages were comparable. However, we found a large differ-
ence in phase offset errors between scanners. In the best
performing scanner, the phase offset errors were so
small that no correction at all was necessary.
From a clinical point of view, the present study indi-
cates that both uncorrected and stationary tissue cor-
rected flow measurements could lead to clinically
relevant differences in flow measurements and poor re-
gurgitation indexing. Without correction the regurgita-
tion severity classification changed in 9 to 17% of the
cases depending on the software program used. How-
ever, this was 10 to 37% with stationary tissue correc-
tion. Incorrect regurgitation classification could
potentially have therapeutic consequences in deciding
whether valvular surgery is indicated. Therefore, neither
strategy (no correction and stationary tissue correction)
is shown to be ideal.
Inherent to PC imaging are phase offset errors caused
by eddy-currents. Previous studies have already shown
that phase offset errors can lead to clinically significant
differences [3, 16–18]. Stationary tissue correction has
been suggested as a reliable method to reduce phase off-
set errors [10] and is implemented into several commer-
cial available post-processing software programs for
CMR analysis (e.g. Medis QFlow (Leiden, The
Netherlands), Circle cvi42 (Cardiovascular Imaging Inc.,
Calgary, Alberta, Canada), SyngoVia (Siemens Health-
care, Erlangen, Germany)). To our knowledge, this is the
first study conducted in a large population in which sta-
tionary tissue correction was shown to worsen 2D flow
measurement accuracy.
This study tested both linear and higher order spatial
interpolation methods using three different software
programs. Lankhaar et al. concluded for pulmonary ar-
tery flow measurements in their single center study that
a first order surface fit, combined with regarding 25% of
the pixels as stationary, minimized velocity offsets [3].
However, Hofman et al. showed in their multicenter
study that the some GE systems require second order
surface fit. Measurement errors after stationary tissue
correction in cardiac output were expected to stay
within an acceptable range for clinical application (0 ±
5%) when using this method [10]. The results of this
study confirm that on our GE Healthcare scanners on
certain scanners a second or third order surface fit was
also preferred over first order surface fit. Nevertheless,
on two of our three scanners no correction was better
than any order of stationary tissue correction. On the
third scanner substantial over- and underestimation
remained despite different order correction methods.
Only using the uncorrected measurements on CMR-3
resulted in cardiac output staying within this range.
Phase offset is not a problem that occurs linearly over
the scan plane and, therefore, a first order correction is
not perfect [6]. However, higher order corrections re-
quire a larger number of pixels with stationary tissue
sufficiently scattered through the whole imaging plane.
Because of insufficient available stationary tissue in the
FOV and especially close to the vessel of interest, sec-
ond, third or even higher order corrections are often un-
reliable. Therefore, it is important that during scanning
the FOV and orientation of the scan plane should be op-
timized to include the maximum amount of stationary
tissue possible.
The magnitude of phase offset errors varied among
scanners, as has been reported in previous studies [9].
Maximum gradient amplitude and slew rate are known
to influence eddy-currents and have proven to be indi-
vidual predictors of phase offset errors [19]. These fac-
tors might have contributed to the variation of
magnitude of phase offset errors we observed between
our three scanners.
In this study, CMR-2 suffered more from eddy cur-
rents. Both with stationary tissue correction and no cor-
rection, measurement errors remained significant and,
therefore, phantom scanning should be advised. Previ-
ously, poor flow quantifying performance of a similar
type of scanner (Discovery MR450) has been reported
[10]. However, variability in velocity offsets before and
after stationary tissue correction on this scanner was lar-
ger in our study than in the previous study. We have no
clear explanation for this observation. On the contrary,
omitting phantom correction on CMR-3 would only lead
to clinically relevant differences in 1% of the measure-
ments. As also shown in this study, phase offset errors
of one scanner differ substantially between patients,
measurements, and slice orientation. Depending on the
accuracy of the flow measurements that is acceptable for
clinical decision making, we advise acquiring phantom
scans in at least 30–50 patients to get familiar with your
local CMR system.
The strength of this study is the number of patients
and its consistent scanning protocol with direct phan-
tom scanning to minimize the influence of temporal in-
stability. Temporal stability was tested and only
acquisitions with temporal stability between the in-vivo
and phantom acquisition of ≤0.6 cm/s were included in
the results of this study. In contrast to smaller previous
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studies, this study included 175 patients with 346 mea-
surements. Furthermore, different stationary tissue order
methods were compared using three different software
programs.
Limitations
This study evaluated only scans acquired with GE
Healthcare CMR scanners. Therefore, our conclusions
might not hold for scanners from a different vendor or
other GE models. However, we have used the same se-
quence settings as Hofman et al. did and no other build-
in correction methods were applied [10]. As the origin
of velocity offset lies within the gradient system (slew
rate and gradient amplitude) and its associated errors,
theoretically no differences between vendors should be
expected [10]. Hence, we expect that these results
should also be valid for CMR systems from different
vendors. Secondly, the static phantom correction, our
reference standard, is not perfect because phase offset
errors drifts over time. However, this drift is limited
within a clinically acceptable range when scanning
within the same imaging session on most systems [9].
Therefore, all phantoms were scanned directly after the
CMR examination was finished. Furthermore, temporal
stability of the phantom correction method was tested
for each scan and studies with a large deviation of phase
offset errors were excluded using the same method as
Hofman et al. used [10]. Finally, in this study only a
retrospective ECG gated PC sequence was used. In pa-
tients with an unstable heart rhythm, prospective ECG
gating may provide more accurate results. However, with
prospective ECG gating the velocity offset varies during
the cardiac cycle depending on the timing after the se-
quence starts running [7]. This studies’ stationary tissue
correction method assumes a constant velocity offset
during the cardiac cycle and this method should, there-
fore, be validated on prospective ECG gated sequences
where a correction per cardiac phase might be more
appropriate.
Conclusion
Phase offset errors had a significant impact on PC CMR
based flow quantification and regurgitation assessment
and varied greatly between scanners. Unexpectedly,
background phase correction using stationary tissue cor-
rection worsened accuracy compared to no correction.
Similar results were obtained independent of spatial
order of interpolation and type of software used. Large
clinically significant deviations in net flow and regurgita-
tion severity index were present after stationary tissue
correction. These results are solely based on images
from GE Healthcare scanners and future research needs
to investigate whether these same conclusions hold for
other vendors as well. In general, careful assessment of
phase offset errors at each individual scanner is essential
to determine whether routine use of phantom correction
is necessary.
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